Inventor · Thousand Oaks, CA, US

Longbin Liu

53Patents
12h-index
147Co-inventors
87Inventor score

Filing activity: Feb 4, 1999 → Nov 16, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US6187777A Compounds and methods which modulate feeding behavior and related diseases Chemistry; Metallurgy 60 Expired
US10519146B2 KRAS G12C inhibitors and methods of using the same Chemistry; Metallurgy 45 Active
US7820665B2 Imidazopyridazine inhibitors of PI3 kinase for cancer treatment Chemistry; Metallurgy 37 Active
US8067548B2 Fusion proteins having mutated immunoglobulin hinge region Chemistry; Metallurgy 33 Active
US7625564B2 Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo Chemistry; Metallurgy 33 Active
US7928140B2 Benzothiazole PI3 kinase modulators for cancer treatment Chemistry; Metallurgy 27 Active
US6583154B1 Compounds and methods which modulate feeding behavior and related diseases Chemistry; Metallurgy 25 Expired
US11090304B2 KRAS G12C inhibitors and methods of using the same Chemistry; Metallurgy 23 Active
US7652009B2 Substituted heterocycles and methods of use Chemistry; Metallurgy 21 Active
US9066954B2 Fused heterocyclic derivatives and methods of use Chemistry; Metallurgy 19 Active
US8524900B2 Fused heterocyclic derivatives and methods of use Chemistry; Metallurgy 19 Active
US6849639B2 Integrin inhibitors and their methods of use Chemistry; Metallurgy 15 Expired
US11285156B2 Substituted piperazines as KRAS G12C inhibitors Human Necessities 11 Active
US8088794B2 Substituted amide derivatives and methods of use Chemistry; Metallurgy 10 Active
US7625555B2 Recombinant human interferon-like proteins Human Necessities 9 Active
US11905281B2 KRAS G12C inhibitors and methods of using the same Chemistry; Metallurgy 8 Active
US7049318B2 Substituted heterocyclic compounds and methods of use Emerging Cross-Sectional Technologies 8 Expired
US8017601B2 Bis-aryl kinase inhibitors and method Chemistry; Metallurgy 7 Active
US7687522B2 Substituted pyridines and pyrimidines and their use in treatment of cancer Chemistry; Metallurgy 7 Active
US8431132B2 Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo Chemistry; Metallurgy 6 Active
US11766436B2 KRAS G12C inhibitors and methods of using the same Chemistry; Metallurgy 5 Active
US8729074B2 Inhibitors of PI3 kinase Human Necessities 5 Active
US8685983B2 Method of treating cancer with substituted amide derivatives Chemistry; Metallurgy 5 Active
US8772480B2 Inhibitors of PI3 kinase and/or mTOR Chemistry; Metallurgy 4 Active
US12083121B2 Substituted piperazines as KRAS G12C inhibitors Human Necessities 4 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.